Skip to main content
. 2017 Aug 18;8(44):77050–77060. doi: 10.18632/oncotarget.20335
Variables N 3-yr PFS(%) [95%CI] p 3-yr OS(%) [95%CI] p
Gender
 Female 14 62 [26–84] 85 [52–96]
 Male 18 14 [235] 0.01 47 [20–71] 0.19
Stage of disease
 Localized 13 73 [37–90] 84 [49–96]
 Metastatic 19 7 [128] 0.0004 43 [15–69] 0.15
SUVmax
 <17 26 41 [20–60] 72 [44–87]
 ≥17 6 0 [0–0] 0.001 21 [1–60] 0.004
SUVpeak
 <12.5 26 36 [17–56] 72 [44–87]
 ≥12.5 6 0 [0–0] 0.002 0 [0–0] <0.001
SUVmean40%
 <8.5 25 44 [23–63] 71 [43–87]
 ≥8.5 7 0 [0–0] 0.017 34 [5–69] 0.018

SUV: Standardized Uptake Value; PFS: Progression Free Survival; OS: Overall Survival; HR: Hazard Ratio; CI: Confidence Interval.